Clinical database/ecrf validation: effective processes and procedures
|
|
- Charlotte Ramsey
- 8 years ago
- Views:
Transcription
1 TITOLO SLIDE Testo Slide Testo Slide Testo Slide Clinical database/ecrf validation: effective processes and procedures IV BIAS ANNUAL CONGRESS Padova September, 26 th 2012 PQE WORKSHOP: What's new in Computerized System Validation, June 2008
2 Topics Under Discussion The regulatory expectations Elements of data quality and integrity The strategy to validate Clinical Database / ecrf systems Key elements regarding the release and the maintenance of validated systems 2
3 Topics Under Discussion The regulatory expectations Elements of data quality and integrity The strategy to validate Clinical Database / ecrf systems Key elements concerning the release and the maintenance of validated systems 3
4 Basic Purpose of Data.. GLP GCP NDA GMP GDP.Maintaining the Chain of Evidence 4
5 Requirements for Computerized System in GCP Regulations Guidelines ICH E6 Good Clinical Practice GCP 21 CFR Part 11 & related Guidance Protection of Privacy Computer system used in clinical investigations GAMP 5 PIC/S CSV 5
6 ICH Requirements for Computerized System ICH E6 Good Clinical Practice ICH E9 Statistical Principles For Clinical Trials 6
7 ICH 6 Requirements for Records And Reports ICH E6-4.9 (Records and reports) The Investigator should ensure the accuracy, completeness, legibility, and timeliness of the data reported to the sponsor in the CRFs and in all required reports Data reported on the CRF, that are derived from source documents, should be consistent with the source documents or the discrepancies should be explained Any change or correction to a CRF should be dated, initialed and explained Sponsors should provide guidance to Investigators on making such corrections. Sponsor should have written procedures to assure that changes or corrections in CRFs made by Sponsor are documented, are necessary and are endorsed by the Investigator GCP 7
8 ICH E6 Req.s for Electronic Data Management ICH E (Trial Management, Data Handling, and Record Keeping) When using electronic trial data handling and/or remote electronic trial data systems, the sponsor should: a. Ensure and document that the electronic data processing system(s) conforms to the sponsor s established requirements for completeness, accuracy, reliability, and consistent intended performance (i.e. validation). b. Maintains SOPs for using these systems. c. Ensure that the systems are designed to grant data changes in such a way that the data changes are documented and that there is no deletion of entered data (i.e. audit trail). d. Maintain a list of the individuals who are authorized to make data change (i.e. authority checks) e. Maintain adequate backup of the data f. Safeguard the blinding, if any (e.g. maintain the blinding during data entry and processing). GCP 8
9 ICH E9 Requirements for Computerized Systems ICH E9-5.8 (Integrity of Data and Computer Software) The credibility of the numerical results of the analysis depends on the quality and VALIDITY of the method and software used both for data management (data entry, storage, verification, correction and retrieval) and also for processing the data statistically. The computer software used for data management and statistical analysis should be reliable and documentation of appropriate software testing procedures should be available. 9
10 21 CFR Part 11 & related Guidance 10
11 21 CFR PART 11 Requirements for Closed Systems CONTROLS FOR ELECTRONIC RECORDS Validation of computer system Human and electronic form equivalent e-copies Record retention Limiting access Audit trails Operational system checks Authority checks Control on validity of input actions Adequate education and training Written polices Control on documentation distribution and change control procedure application 11
12 21 CFR PART 11 Requirements for Closed Systems CONTROLS FOR ELECTRONIC SIGNATURES Using Electronic Signature when required by the predicate rule(s) Electronic Signature manifestation Electronic Signature / Electronic Record linking Procedure for managing attribution and use of ES 12
13 21 CFR PART 11 Requirements for Open Systems Controls for Closed System; several requirements (i.e. Device Checks) might be enforced Document encryption Digital signatures standards PLUS 13
14 Computerized System SOFTWARE HARDWARE Firmware OPERATING PROCEDURES AND PEOPLE EQUIPMENT COMPUTER SYSTEM (Controlling System) INFRASTRUCTURE (NETWORK) COMPUTERISED SYSTEM OPERATING ENVIRONMENT CONTROLLED FUNCTION OR PROCESS (PICS/S - Good Practices For Computerised Systems In Regulated GxP Environments). 14
15 Computerized System A computerized system is composed of the computer system and the controlled function or process. The computer system is composed of all computer hardware, firmware, installed devices, and software controlling the operation of the computer. The controlled function may be composed of equipment to be controlled and operating procedures that define the function of such equipment, or it may be an operation, which does not require equipment other than the hardware in the computer system. Interfaces and networked functions through LAN and WAN are aspects of the computerized system and operating environment potentially linking a multitude of computers and applications. (PICS/S - Good Practices For Computerized Systems In Regulated GxP Environments) 15
16 Computer System Validation CSV is the documented evidence, to a high degree of assurance, that a computer system performs its intended functions accurately and reliably. Documented evidence High degree of assurance intended functions accurately and reliably 16
17 GAMP 5 17
18 GAMP 5 Drivers 18 18
19 V Model Plan Specify RISK MANAGEMENT Verify Report Build 19
20 Managing the handle of the spoon 20
21 Topics Under Discussion The regulatory expectations Elements of data quality and integrity The strategy to validate Clinical Database / ecrf systems Key elements concerning the release and the maintenance of validated systems 21
22 Data Quality DATA SHOULD BE attributable, legible, contemporaneous (timeliness), original accurate A L C O A regardless the format PAPER format = ELECTRONIC format 22
23 ALCOA Attributable data is identified with a specific subject and a specific observer and recorder. (Password, audit trail and e-signature) Legible data are readable and understandable by humans (reports, tables, and listings) Contemporaneous data are recorded at the time they are generated or observed. (Time stamps and time-limited entry) Original data are recorded for the first time. (Source data and meta data) Accurate data are correct (Calculations, algorithms, analyses, and transmissions) 23
24 Data Quality: WHAT ARE WE LOOKING FOR? Trustworthiness of electronic records is ensured by appropriate measures for: LIMIT ACCESS PREVENT DATA MODIFICATION Security Integrity CHANGE CONTROL LINK RAW DATA AND RESULT Traceability WHO DID WHAT, WHEN AND WHY? PREVIOUS ENTRIES MUST NOT BE OBSCURED 24
25 . Along the whole data lifecycle Data Entry Data transfer from external sources (laboratory data, measurement equipment data, etc.) to the clinical database Data extraction Data Set preparation and transfer 25
26 Outcomes of inspections Data integrity: companies need to provide assurance to the Regulatory Authorities of the integrity of data; Quality and reliability of software and computerized systems: in accordance with their intended uses (this is another way of saying validate the systems you use); Record Keeping: Regulatory Authorities expects to see evidence or records created at the time of the activity and not after the fact. 26
27 Record integrity Company s records provide the proof of either compliance or noncompliance. Inspectors look at documents and records, and as it has been noted, sloppy records are a reflection of sloppy compliance Example of Record control violations : Missing validation documentation Inadequate documentation Inaccurate registrations Capability to alter/delete records Record retention Missing records 27
28 Topics Under Discussion The regulatory expectations Elements of data quality and integrity The strategy to validate Clinical Database / ecrf systems Key elements concerning the release and the maintenance of validated systems 28
29 Computer Systems used in Clinical Study Randomization system IXRS system Data Collection System Data Entry (In house data entry: Clinical Database, Remote Data Entry: ecrf) Data querying Data cleaning Drug Supplies Accountability System Statistical System Drug Safety System Electronic Document Management System 29
30 Data Collection Main Process Data Capture Data Entry Data Querying Data Cleaning Data Validation Data Reporting 30
31 Data Collection Paper-Based Process Medical Records Paper CRF Clinical DB CDMS Investigational Site Sponsor/CRO 1. Data are registered in the paper Medical Records 2. Data are reported in the Paper CRF 3. Data are entered in the Clinical DB (in house data entry) 31
32 Data Collection Electronic Web-Based Process Medical Case History Records Network Clinical DB ecrf Investigational Site Sponsor/CRO 1. Data are registered in the paper Medical Records 2. Data are entered directly in the Clinical DB through remote access. 32
33 Data Collection Systems: Design Workflow Library creation (Global and study-specific) Study creation and verification Study approval and release for use 33
34 Data Collection Systems: Data Entry and Validation Process Data Entry (single/double entry) Data validation and cleaning DB lock/export data 34
35 Platform Layer Multi Layer Systems 35
36 Risk Based Approach System Risk Assessment Functional Risk Analysis 36
37 System Risk Assessment System Risk Assessment PROCESS DATA SYSTEM CRITICALITY COMPLEXITY SW CATEGORY GOLD RULE VALIDATION EFFORT SHOULD BE MAXIMUN FOR HIGH CRITICAL AND COMPLEX SYSTEMS. 37
38 GAMP Category GAMP 5 SW Category Validation Approach Example Software / System Type I Infrastructure Record version (inc. service pack). Verify correct installation. Middleware, Operating Systems, Statistical Packages. Examples: Unix, Windows, Oracle, Databases, C++. Excel II Firmware III Nonconfigured IV Configurable V Custom THIS CATEGORY IS NO LONGER USED Record version number and verify correct installation. Risk based tests against specifications/requirements as dictated by use (calibration may substitute for qualification for simple systems). Record version number and verify correct installation. Risk based tests against specifications/ requirements to demonstrate application works as designed Procedures in place for managing data Validate lifecycle process for complete system. Firmware-based applications, COTS software including non-customized PLC ladder code). Examples: instruments, balances, scales, bar code scanners, spreadsheets LIMS, Data Acquisition Systems, SCADA, ERP, Clinical Trial Monitoring, DCS, ADR Reporting, CDS, EDMS, Building Managements Systems, CRM, Spreadsheets, Simple Human, Machine Interface Source code developed to client needs. Example: Applications developed internally. 38
39 Function Risk Assessment Functional Risk Analysis SYSTEM FUNCTIONS CLASS OF RISK TESTING EFFORT 39
40 FMEA Methodology type of failures effects and impacts of failures (Severity) probable causes of failures probability of failure causes (Occurence) ability to detect failures (Detection) CAUSE FAILURE EFFECTS
41 Platform (system) Two layers validation approach Validation Report Validation Plan Study Requirements Design Specification Study Qualification Study Configuration User Requirements OQ PQ System Specification IQ Installation 41
42 Platform (system) Two layers validation approach Validation Report Study 1 Study 2 Study n Study Study Study Study Requirements Requirements Requirements Validation Plan Design Specification Study Qualification Design Specification Study Qualification Design Specification Study Qualification Configuration Configuration Configuration User Requirements PQ OQ System Specification IQ Installation 42
43 Validation Deliverables: User Requirements Specification PLATFORM (SYSTEM) User Requirements: document describing the requirements applicable to the system (platform) Regulatory Requirements General Requirements Process Requirements STUDY SPECIFIC User Requirements: document or set of documents describing the study specific needs 43
44 Study User Requirements Specification Study Protocol Visit Flow CRF Pages List of Variables and relevant characteristics Codelists Data Validation Checks 44
45 Platform Testing Strategy OQ Part 11 Compliance High Risk Functions IQ Installation/ Configuraiton Platform Qualification PQ Operative flow : Study Design 45
46 Study Specific Testing Strategy OQ Data Validation Checks IQ Layout 1 1 : Study visits, Data entry screens, Labels, Codelists Study Qualification PQ Data Entry 46
47 Traceability Matrix A traceability matrix between User Requirements, Specification and Testing must be in place ensuring (and allowing to verify) that critical requirements/functions have been covered and tested System Traceability Matrix Study Specific Traceability Matrix 47
48 Release Approval flow of Clinical Database/eCRF Development of guidance for completion management Deployment of Clinical Database/eCRF Training material User account activation Validation statement Version History 48
49 Topics Under Discussion The regulatory expectations Elements of data quality and integrity The strategy to validate Clinical Database / ecrf systems Key elements concerning the release and the maintenance of validated systems 49
50 Operational Phase Key Elements Keep the system under control! Ensure record integrity! ACCESS CONTROL PW MANAGEMENT INCIDENT MANAGEMENT BACKUP /RESTORE ARCHIVING CHANGE CONTROL CONFIGURATION MANAGEMEN PERIODIC REVIEW TRAINING SECURITY TRACEABILITY MAINTENANCE 50
51 Maintenance Availability of the service Help Desk Standard Operating Procedures Change Management Incident Tracking Security Back up and Restore Disaster Recovery and Business Continuity Electronic data archiving and maintenance Periodic Review 51
52 Change Management definition Change Management consists of the change control and configuration management processes within an organization Fundamental to allowing a system to evolve, while maintaining control of that system. It is the process which controls the ongoing evolution of system components by ensuring that changes to components are recorded, evaluated, authorized and managed. Configuration Management CHANGE MANAGEMENT Change Control
53 Change Management Clinical Study Change Management Substantial Amendment (s) Approval of Substantial Amendment (s) Impact evaluation on ecrf EN D ecrf change implementation ecrf change deployment System Change Management 53
54 Training Training on Clinical Database/eCRF should include system security issues (i.e. good user account management! And good password management!) Documentation that the user account were activate ONLY AFTER training Availability of training records (SIV, on going following modification) 54
55 Access Control Physical Controlled Facility Trained and qualified personnel Logical Security Appropriately configured HW (firewall, routers, switches) User authentication User profiles (authorization levels) Data segregation 55
56 Conclusions 56
57 Validation = Good Business Practice Properly developed systems meet business needs, work as intended, work consistently and are relatively easy to maintain Properly maintained systems will continue to meet business needs, will continue to work as intended, will continue to work consistently, will continue to be relatively easy to maintain Business Impact Regulatory Impact Increased efficiency Decreased risk of noncompliance Increased quality of information Decreased cost of doing Decreased risk of nasty stuff business (e.g., warning letters, rejection of Decreased risk of client loss submissions) Do it right the first time 57
58 Thanks for your attention Mobile: Tel: Fax: Mail: Giulia M. Valsecchi GCP & Pharmacovigilance Compliance Manager Pharma Quality Europe If you have any question, feel free to contact me
Testing Automated Manufacturing Processes
Testing Automated Manufacturing Processes (PLC based architecture) 1 ❶ Introduction. ❷ Regulations. ❸ CSV Automated Manufacturing Systems. ❹ PLCs Validation Methodology / Approach. ❺ Testing. ❻ Controls
More informationComputerised Systems. Seeing the Wood from the Trees
Computerised Systems Seeing the Wood from the Trees Scope WHAT IS A COMPUTERISED SYSTEM? WHY DO WE NEED VALIDATED SYSTEMS? WHAT NEEDS VALIDATING? HOW DO WE PERFORM CSV? WHO DOES WHAT? IT S VALIDATED -
More informationFrom paper to electronic data
From paper to electronic data Bioindustrypark, October 10, 2013 Dr Alessandra Grande Ivrea GxP Test Facility QA Manager, Head Global BMT QA Research & Development Quality Assurance MerckSerono RBM Outline
More informationData Management and Good Clinical Practice Patrick Murphy, Research Informatics, Family Health International
Data Management and Good Clinical Practice Patrick Murphy,, Family Health International 1 What is GCP? Good Clinical Practice is an international ethical and scientific quality standard for designing,
More information1/30/2013. Agenda. Electronic Signatures/ Informed Consent
2013 UC Compliance & Audit Symposium Recordkeeping Matters: Part 11 Compliance Rachel Nosowsky ~ Acting Deputy General Counsel Rachel.Nosowsky@ucop.edu ~ (510) 987-9407 Agenda Electronic Signatures/Informed
More informationINTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to
INTRODUCTION This book offers a systematic, ten-step approach, from the decision to validate to the assessment of the validation outcome, for validating configurable off-the-shelf (COTS) computer software
More informationGCP INSPECTORS WORKING GROUP <DRAFT> REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS
European Medicines Agency London, 17 October 2007 Doc. Ref. EMEA/505620/2007 GCP INSPECTORS WORKING GROUP REFLECTION PAPER ON EXPECTATIONS FOR ELECTRONIC SOURCE DOCUMENTS USED IN CLINICAL TRIALS
More informationComputerized System Audits In A GCP Pharmaceutical Laboratory Environment
IVTGXP_july06.qxd 6/28/06 1:09 PM Page 36 Computerized System Audits In A GCP Pharmaceutical Laboratory Environment By Maintaining data integrity for both clinical laboratory processes and patient data
More informationImplementing Title 21 CFR Part 11 (Electronic Records ; Electronic Signatures) in Manufacturing Presented by: Steve Malyszko, P.E.
Implementing Title 21 CFR Part 11 (Electronic Records ; Electronic Signatures) in Manufacturing Presented by: Steve Malyszko, P.E. President & CEO Agenda Introduction Who is Malisko Engineering? Title
More informationMHRA GMP Data Integrity Definitions and Guidance for Industry January 2015
MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This
More informationManaging & Validating Research Data
Research Management Standard Operating Procedure ISOP-H02 VERSION / REVISION: 2.0 EFFECTIVE DATE: 01 03 12 REVIEW DATE: 01 03 14 AUTHOR(S): CONTROLLER(S): APPROVED BY: Information Officer; NBT Clinical
More informationMHRA GMP Data Integrity Definitions and Guidance for Industry March 2015
MHRA GMP Data Integrity Definitions and Guidance for Industry Introduction: Data integrity is fundamental in a pharmaceutical quality system which ensures that medicines are of the required quality. This
More informationGuidance for electronic trial data capturing of clinical trials
Guidance for electronic trial data capturing of clinical trials 1 st November, 2007 Japan Pharmaceutical Manufacturing Association pg. 1 Table of Contents 1. Background... 3 2. Purpose... 3 3. Scope...
More informationWelcome Computer System Validation Training Delivered to FDA. ISPE Boston Area Chapter February 20, 2014
Welcome Computer System Validation Training Delivered to FDA ISPE Boston Area Chapter February 20, 2014 1 Background Training Conducted on April 24, 2012 Food & Drug Administration Division of Manufacturing
More informationReflection paper on expectations for electronic source data and data transcribed to electronic data collection tools in clinical trials
09 June 2010 EMA/INS/GCP/454280/2010 GCP Inspectors Working Group (GCP IWG) Reflection paper on expectations for electronic source data and data transcribed to electronic data collection tools in clinical
More informationData Management Unit Research Institute for Health Sciences, Chiang Mai University
Data Management Unit Research Institute for Health Sciences, Chiang Mai University Clinical Data Management is the process of handling data from clinical trials. The inherent goal of any clinical data
More informationUsing SharePoint 2013 for Managing Regulated Content in the Life Sciences. Presented by Paul Fenton President and CEO, Montrium
Using SharePoint 2013 for Managing Regulated Content in the Life Sciences Presented by Paul Fenton President and CEO, Montrium Overview Informative Webinar that aims to provide an overview of how SharePoint
More informationSupplement to the Guidance for Electronic Data Capture in Clinical Trials
Supplement to the Guidance for Electronic Data Capture in Clinical Trials January 10, 2012 Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association Note: The original language of this
More informationElectronic Data Capture - MACRO. Anja Fischer, Thomas Müller
Electronic Data Capture - MACRO Anja Fischer, Thomas Müller Agenda Purpose of Electronic Data Capture (EDC) Regulatory Requirements EDC-System MACRO Clinical Trial Support for ELN by WP 3 (CICS) Costs
More informationGuidance for Industry COMPUTERIZED SYSTEMS USED IN CLINICAL TRIALS
Guidance for Industry COMPUTERIZED SYSTEMS USED IN CLINICAL TRIALS U.S. Department of Health and Human Services Food and Drug Administration Center for Biologic Evaluation and Research (CBER) Center for
More informationThis interpretation of the revised Annex
Reprinted from PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE July/August 2011, Vol. 31 No. 4 www.ispe.org Copyright ISPE 2011 The ISPE GAMP Community of Practice (COP) provides its interpretation
More informationFull Compliance Contents
Full Compliance for and EU Annex 11 With the regulation support of Contents 1. Introduction 2 2. The regulations 2 3. FDA 3 Subpart B Electronic records 3 Subpart C Electronic Signatures 9 4. EU GMP Annex
More informationFDA Regulation of Electronic Source Data in Clinical Investigations
FDA Regulation of Electronic Source Data in Clinical Investigations Q1 Productions Second Annual Innovations in Clinical Data Management Conference, Arlington, VA Mahnu Davar Presented on Oct. 28, 2014
More informationOMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT
OMCL Network of the Council of Europe QUALITY ASSURANCE DOCUMENT PA/PH/OMCL (08) 69 3R Full document title and reference Document type VALIDATION OF COMPUTERISED SYSTEMS Legislative basis - CORE DOCUMENT
More informationISCT Cell Therapy Liaison Meeting AABB Headquarters in Bethesda, MD. Regulatory Considerations for the Use of Software for Manufacturing HCT/P
ISCT Cell Therapy Liaison Meeting AABB Headquarters in Bethesda, MD September 10, 2009 David Doleski, Team Leader, Branch 2 Division of Manufacturing and Product Quality (DMPQ) Office of Compliance and
More informationIT General Controls Domain COBIT Domain Control Objective Control Activity Test Plan Test of Controls Results
Acquire or develop application systems software Controls provide reasonable assurance that application and system software is acquired or developed that effectively supports financial reporting requirements.
More informationManual 074 Electronic Records and Electronic Signatures 1. Purpose
1. Purpose The purpose of this document is to provide an interpretation of FDA 21 CFR Part 11, Electronic Records; Electronic Signatures (ER/ES) and to provide guidance for acceptable practices in the
More informationQualification Guideline
Qualification Guideline June 2013 Disclaimer: This document is meant as a reference to Life Science companies in regards to the Microsoft O365 platform. Montrium does not warrant that the use of the recommendations
More informationGuidance for Industry
Guidance for Industry Electronic Source Data in Clinical Investigations U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for
More informationUNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE
UNIVERSITY OF LEICESTER, UNIVERSITY OF LOUGHBOROUGH & UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST JOINT RESEARCH & DEVELOPMENT SUPPORT OFFICE STANDARD OPERATING PROCEDURES University of Leicester (UoL)
More informationREGULATIONS COMPLIANCE ASSESSMENT
ALIX is free software: you can redistribute it and/or modify it under the terms of the GNU General Public License as published by the Free Software Foundation. REGULATIONS COMPLIANCE ASSESSMENT BUSINESS
More informationOECD DRAFT ADVISORY DOCUMENT 16 1 THE APPLICATION OF GLP PRINCIPLES TO COMPUTERISED SYSTEMS FOREWARD
OECD DRAFT ADVISORY DOCUMENT 16 1 THE APPLICATION OF GLP PRINCIPLES TO COMPUTERISED SYSTEMS FOREWARD 1. The following draft Advisory Document will replace the 1995 OECD GLP Consensus Document number 10
More informationTIBCO Spotfire and S+ Product Family
TIBCO Spotfire and S+ Product Family Compliance with 21 CFR Part 11, GxP and Related Software Validation Issues The Code of Federal Regulations Title 21 Part 11 is a significant regulatory requirement
More informationElectronic records and electronic signatures in the regulated environment of the pharmaceutical and medical device industries
White Paper No 01 I December 2010 Implementation of 21 CFR Part 11 in the epmotion Software Electronic records and electronic signatures in the regulated environment of the pharmaceutical and medical device
More informationValidation Consultant
Personal Data Name Title Validation Consultant Contact jsb-validierung Zwischen den Bächen 9 D 79618 Rheinfelden Tel: +49 7623 79 49 82 Mobile: +49 172 737 84 86 E-Mail: Internet: jsb-val@online.de http://www.jsb-validierung.de
More informationTopics. From paper to EDC. From paper to EDC. From paper to EDC. From paper to EDC
Topics Infermed MACRO - Electronic Data Capture according to GCP Dipl. Inf. A. Fischer I. II. Requirements by GCP III. IV. Heidelberg / January 28, 2008 2 History Idea born in 1970s 1980 - early 1990s:
More informationGuidance for Industry Computerized Systems Used in Clinical Investigations
Guidance for Industry Computerized Systems Used in Clinical Investigations U.S. Department of Health and Human Services Food and Drug Administration (FDA) Office of the Commissioner (OC) May 2007 Guidance
More informationClinical Data Management (Process and practical guide) Dr Nguyen Thi My Huong WHO/RHR/RCP/SIS
Clinical Data Management (Process and practical guide) Dr Nguyen Thi My Huong WHO/RHR/RCP/SIS Training Course in Sexual and Reproductive Health Research Geneva 2012 OUTLINE Clinical Data Management CDM
More informationConsiderations for validating SDS Software v2.x Enterprise Edition for the 7900HT Fast Real-Time PCR System per the GAMP 5 guide
WHITE PAPER SDS Software v2.x Enterprise Edition Considerations for validating SDS Software v2.x Enterprise Edition for the 7900HT Fast Real-Time PCR System per the GAMP 5 guide This white paper describes
More informationComputer System Validation - It s More Than Just Testing
Computer System Validation - It s More Than Just Testing Introduction Computer System Validation is the technical discipline that Life Science companies use to ensure that each Information Technology application
More information21 CFR Part 11 Checklist
21 CFR Part 11 Checklist GUIDE NOTOCORD - 113 Chemin de Ronde - 78290 Croissy-sur-Seine www.notocord.com my.notocord.com support@notocord.com +33 (0)1 34 80 00 00 1. Preliminary information 1.1. Purpose
More informationThis is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled.
This is a controlled document. The master document is posted on the JRCO website and any print-off of this document will be classed as uncontrolled. Researchers and their teams may print off this document
More informationLabChip GX/GXII with LabChip GxP Software
Regulatory Compliance LabChip GX/GXII with LabChip GxP Software Supporting Regulatory Compliance Caliper LabChip GX/GXII suite of instruments provides automated electrophoresis to analyze quality, size,
More informationAgilent MicroLab Software with Spectroscopy Configuration Manager and Spectroscopy Database Administrator (SCM/SDA)
Agilent MicroLab Software with Spectroscopy Configuration Manager and Spectroscopy Database Administrator (SCM/SDA) Compliance with 21 CFR Part 11 Introduction Part 11 in Title 21 of the Code of Federal
More informationOracle WebCenter Content
Oracle WebCenter Content 21 CFR Part 11 Certification Kim Hutchings US Data Management Phone: 888-231-0816 Email: khutchings@usdatamanagement.com Introduction In May 2011, US Data Management (USDM) was
More informationConsiderations When Validating Your Analyst Software Per GAMP 5
WHITE PAPER Analyst Software Validation Service Considerations When Validating Your Analyst Software Per GAMP 5 Blair C. James, Stacy D. Nelson Introduction The purpose of this white paper is to assist
More informationClinical Data Management Overview
The 2 nd Clinical Data Management Training Clinical Data Management Overview Andrew Taylor ( 安 泰 乐 ), M.S. Head of Clinical Data Management August 30, 2010 Learning Objectives Overview of Process Related
More informationClinical Data Management (Process and practical guide) Nguyen Thi My Huong, MD. PhD WHO/RHR/SIS
Clinical Data Management (Process and practical guide) Nguyen Thi My Huong, MD. PhD WHO/RHR/SIS Training Course in Sexual and Reproductive Health Research Geneva 2013 OUTLINE Overview of Clinical Data
More informationThe Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor
The Concept of Quality in Clinical Research Dorota Śwituła Senior Clinical Quality Assurance Advisor 1 Agenda What is quality? How we define quality in clinical research? The standard components of a Quality
More informationGUIDELINES ON VALIDATION APPENDIX 5 VALIDATION OF COMPUTERIZED SYSTEMS
May 2016 Draft document for comment 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 GUIDELINES ON VALIDATION APPENDIX
More informationTEMPLATE DATA MANAGEMENT PLAN
TEMPLATE DATA MANAGEMENT PLAN ICRIN (QM sub group) Version: XX Date: XXXXXXX Page 1 of 6 1.0 Document Ownership The Data Management Plan (DMP) will be initiated and subsequently owned by the Data Manager
More informationNetwork Qualification: What Is it; What Does it Involve?
JVT_May2007.qxd 4/23/07 8:04 AM Page 210 Network Qualification: What Is it; What Does it Involve? BY ESRA GUVEN, B.Sc.EE, PMP, CCNA WHAT IS A NETWORK? The Food and Drug Administration (FDA) defines a network
More informationDesigning a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence
Designing a CDS Landscape that Ensures You Address the Latest Challenges of the Regulatory Bodies with Ease and Confidence Heather Longden Senior Marketing Manager, Informatics Regulatory Compliance 2015
More informationInternational GMP Requirements for Quality Control Laboratories and Recomendations for Implementation
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. ludwig_huber@labcompliance.com Overview GMP requirements for Quality Control laboratories
More informationInfinityQS SPC Quality System & FDA s 21 CFR Part 11 Requirements
InfinityQS SPC Quality System & FDA s 21 CFR Part 11 Requirements www.infinityqs.com Copyright InfinityQS International Table of Contents Overview... FDA s 21 CFR Part 11 Requirements... PART 11 ELECTRONIC
More informationServices Providers. Ivan Soto
SOP s for Managing Application Services Providers Ivan Soto Learning Objectives At the end of this session we will have covered: Types of Managed Services Outsourcing process Quality expectations for Managed
More informationEclipsys Sunrise Clinical Manager Enterprise Electronic Medical Record (SCM) and Title 21 Code of Federal Regulations Part 11 (21CFR11)
Eclipsys Sunrise Clinical Manager Enterprise Electronic Medical Record (SCM) and Title 21 Code of Federal Regulations Part 11 (21CFR11) The title 21 code of federal regulations part 11 deals with an institutions
More informationEmpower TM 2 Software
Empower TM 2 Software 21 CFR PART 11 COMPLIANCE ASSESSMENT Revision A, December, 2005 1 of 14 Waters Corporation Note: Information presented in this document assumes that the appropriate Empower 2 System
More informationDAIDS Appendix 2 No.: DWD-POL-DM-01.00A2. Data Management Requirements for Central Data Management Facilities
DAIDS Appendix 2 No.: DWD-POL-DM-01.00A2 Data Management Requirements for Central Data Management Facilities The following clinical trial data management requirements must be met in order to ensure the
More informationNova Southeastern University Standard Operating Procedure for GCP. Title: Electronic Source Documents for Clinical Research Study Version # 1
Nova Southeastern University Standard Operating Procedure for GCP Title: Electronic Source Documents for Clinical Research Study Version # 1 SOP Number: OCR-RDM-006 Effective Date: August 2013 Page 1 of
More informationQUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH
QUALITY CONTROL AND QUALITY ASSURANCE IN CLINICAL RESEARCH Martin Valania, Executive Director, Corporate QA and Compliance Introduction Pharmaceutical companies recognize the benefits of carefully managing
More informationDocument Number: SOP/RAD/SEHSCT/007 Page 1 of 17 Version 2.0
Standard Operating Procedures (SOPs) Research and Development Office Title of SOP: Computerised Systems for Clinical Trials SOP Number: 7 Version Number: 2.0 Supercedes: 1.0 Effective date: August 2013
More informationA Web-Based Data Management System for Small And Medium Clinical Trials
A Web-Based Data Management System for Small And Medium Clinical Trials Tzafi Glass and Diklah Geva EMR-IBS 2007 January 23-25, 2007 Eilat Israel 2007, Diklah Geva IntegriStat Introduction-1 A Web based
More informationINSERT COMPANY LOGO HERE BEST PRACTICES RESEARCH
INSERT COMPANY LOGO HERE BEST PRACTICES RESEARCH Background and Company Performance Industry Challenges esource: Electronic Clinical Trial Solution Clinical trial sponsors and clinical research organizations
More informationMonitoring manufacturing, production and storage environments in the pharmaceutical industry
Application Description AD/RandC/005-EN Monitoring manufacturing, production and storage environments in the pharmaceutical industry - Provides independent verification and validation of the manufacture,
More informationGuidance for Industry
Guidance for Industry Electronic Source Data in Clinical Investigations DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft
More informationCompliance Response SIMATIC SIMATIC PCS 7 V8.1. Electronic Records / Electronic Signatures (ERES) Edition 03/2015. Answers for industry.
SIMATIC SIMATIC PCS 7 V8.1 Electronic Records / Electronic Signatures (ERES) Compliance Response Edition 03/2015 Answers for industry. Compliance Response Electronic Records / Electronic Signatures (ERES)
More informationThe FDA recently announced a significant
This article illustrates the risk analysis guidance discussed in GAMP 4. 5 By applying GAMP s risk analysis method to three generic classes of software systems, this article acts as both an introduction
More informationBarnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA
Barnett International and CHI's Inaugural Clinical Trial Oversight Summit June 4-7, 2012 Omni Parker House Boston, MA This presentation is the property of DynPort Vaccine Company LLC, a CSC company, and
More information21 CFR PART 11 ELECTRONIC RECORDS, ELECTRONIC SIGNATURES 21.11.2013. 21 CFR Part 11 Compliance PLA 2.1
21 CFR PART 11 ELECTRONIC RECORDS, ELECTRONIC SIGNATURES Compliance of PLA 2.1 21.11.2013 21 CFR Part 11 Compliance PLA 2.1 SEC. 11.2 IMPLEMENTATION. (a) For records required to be maintained but not submitted
More informationTools to Aid in 21 CFR Part 11 Compliance with EZChrom Elite Chromatography Data System. White Paper. By Frank Tontala
Tools to Aid in 21 CFR Part 11 Compliance with EZChrom Elite Chromatography Data System White Paper By Frank Tontala Agilent Technologies Software & Informatics Life Sciences & Chemical Analysis Group
More informationAssuring E Data Integrity and Part 11 Compliance for Empower How to Configure an Empower Enterprise
Assuring E Data Integrity and Part 11 Compliance for Empower How to Configure an Empower Enterprise 2013 Waters Corporation 1 Agenda Electronic Record regulations, Compliance Policy Guides and Warning
More informationCONTENTS. List of Tables List of Figures
Prelims 13/3/06 9:11 pm Page iii CONTENTS List of Tables List of Figures ix xi 1 Introduction 1 1.1 The Need for Guidance on ERP System Validation 1 1.2 The Need to Validate ERP Systems 3 1.3 The ERP Implementation
More informationWhat is Clinical Data Management
What is Clinical Data Management Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications, database systems to support collection,
More informationThe Impact of 21 CFR Part 11 on Product Development
The Impact of 21 CFR Part 11 on Product Development Product development has become an increasingly critical factor in highly-regulated life sciences industries. Biotechnology, medical device, and pharmaceutical
More informationIntroduction to Cloud Computing What is SaaS? Conventional vs. SaaS Methodologies Validation Requirements Change Management Q&A
Best Practices for Validation of a Software as a Service (SaaS) Customer Relationship Management (CRM) Solution Presented By: Gregg Mauriello Validation Manager Elise Miner Associate Validation Manager
More informationMonitoring the autoclaving process in the pharmaceutical industry
Application Description AD/RandC/006-EN Monitoring the autoclaving process in the pharmaceutical industry - Provides independent verification and validation monitoring of the autoclaving process - Enables
More informationCloud Computing: What needs to Be Validated and Qualified. Ivan Soto
Cloud Computing: What needs to Be Validated and Qualified Ivan Soto Learning Objectives At the end of this session we will have covered: Technical Overview of the Cloud Risk Factors Cloud Security & Data
More informationClinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems
Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems to support collection, cleaning and management of subject
More informationOrganization Profile. IT Services
Introduction In today s scientific and medical world, various issues in clinical trials and research have permeated every society and every field in medicine. Ethics and in particular the quality of research
More informationEUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union
EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Pharmaceuticals Brussels, SANCO/C8/AM/sl/ares(2010)1064599 EudraLex The Rules Governing Medicinal Products
More informationWhat is necessary to provide good clinical data for a clinical trial?
What is necessary to provide good clinical data for a clinical trial? Alain Barrois, Assistant Clinical Trials Operations Manager #EBMT2015 www.ebmt.org Is this a (typical) clinical trial? 2 Agenda Introduction
More informationTHE ROLE OF WATERS NUGENESIS SDMS IN 21 CFR PART 11 COMPLIANCE
THE ROLE OF WATERS NUGENESIS SDMS IN 21 CFR PART 11 COMPLIANCE The objective of this article is to discuss the 21 CFR Part 11 compliance utility of the Waters NuGenesis Scientific Data Management System
More informationWhat is the correct title of this publication? What is the current status of understanding and implementation?
GMP Rules and Guidelines in 2013 for Computer System Validation / Computerises Systems / Electronic Records and Signatures/ IT Infrastructure and Application Compliance: What is the correct title of this
More information21 CFR Part 11 Compliance Using STATISTICA
21 CFR Part 11 Compliance Using STATISTICA Last Updated: April 2003 This document was updated to reflect the FDA s latest guidance (released February, 2003) and the withdrawal of previous guidance.! STATSOFT
More informationValidating Enterprise Systems: A Practical Guide
Table of Contents Validating Enterprise Systems: A Practical Guide Foreword 1 Introduction The Need for Guidance on Compliant Enterprise Systems What is an Enterprise System The Need to Validate Enterprise
More informationEffiValidation 3.0 software basic training module
EffiValidation 3.0 software basic training module Oct 3, 2012 www.effichem.com Agenda EffiChem company EffiValidation 3.0 software : overview International standards and guidelines Software features Structure
More informationFDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997)
www.qadata.co.za Introduction FDA Title 21 CFR Part 11:Electronic Records; Electronic Signatures; Final Rule (1997) INITIAL REGULATION RELEASED High profile audit findings Industry complaints to wasting
More informationA Pragmatic Approach to the Testing of Excel Spreadsheets
A Pragmatic Approach to the Many GxP critical spreadsheets need to undergo validation and testing to ensure that the data they generate is accurate and secure. This paper describes a pragmatic approach
More informationHESI: Fetal Imaging Workshop 21 CFR Part 11 Electronic Records & Signatures. Presented by: Jonathan S. Helfgott
HESI: Fetal Imaging Workshop 21 CFR Part 11 Electronic Records & Signatures Presented by: Jonathan S. Helfgott Director of Regulatory Affairs, Stage 2 Innovations Jonathan@stage2innovations.com Disclaimer
More informationAssessment of Vaisala Veriteq vlog Validation System Compliance to 21 CFR Part 11 Requirements
/ WHITE PAPER Assessment of Vaisala Veriteq vlog Validation System Compliance to 21 CFR Part 11 Requirements The 21 CFR Part 11 rule states that the FDA view is that the risks of falsification, misinterpretation,
More informationThe use of computer systems
Technology Update Computer Systems Validation, Part 1 Software Purchase and GCP Compliance Teri Stokes Teri Stokes, PhD, is senior consultant and director of GXP International, 131 Sudbury Road, Concord,
More information21 CFR Part 11 Electronic Records & Signatures
Gap Analysis - Checklist 21 CFR Part 11 Electronic Records & Signatures his document is a proposal and starting point only. he type and extent of documentation depends on the process environment. he proposed
More informationCONTENTS. 1 Introduction 1
Prelims 25/7/06 1:49 pm Page iii CONTENTS List of Tables List of Figures Preface 1 1 2 Infrastructure Lifecycle Approach Recommendation and Conceptualization Design Design Reviews Development and Integration
More informationIntland s Medical Template
Intland s Medical Template Traceability Browser Risk Management & FMEA Medical Wiki Supports compliance with IEC 62304, FDA Title 21 CFR Part 11, ISO 14971, IEC 60601 and more INTLAND codebeamer ALM is
More informationrsdm and 21 CFR Part 11
rsdm and 21 CFR Part 11 Meeting the 21 CFR Part 11 Burden without Overburdening The right solutions for smaller biopharma. Nothing more. Nothing less. Prepared by: Ken VanLuvanee www.virtualregulatorysolutions.com
More informationManaging Data in Clinical Research. Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group
Managing Data in Clinical Research Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Clinical data management (CDM) is a multidisciplinary
More informationHow Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program
How Industry Can Partner with FDA in Defining a Risk- Based Monitoring Program Presenter: Jan Holladay Pierre, MPH Quality Principal Leader DynPort Vaccine Company LLC, A CSC Company This presentation
More informationGAMP 4 to GAMP 5 Summary
GAMP 4 to GAMP 5 Summary Introduction This document provides summary information on the GAMP 5 Guide and provides a mapping to the previous version, GAMP 4. It specifically provides: 1. Summary of Need
More informationGOOD LABORATORY PRACTICE (GLP) GUIDELINES FOR THE VALIDATION OF COMPUTERISED SYSTEMS. Working Group on Information Technology (AGIT)
GOOD LABORATORY PRACTICE (GLP) GUIDELINES FOR THE VALIDATION OF COMPUTERISED SYSTEMS Working Group on Information Technology (AGIT) Release Date: 14 December 2007 Version: 02 AGIT - Validation of Computerised
More information